These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 24833114)

  • 21. Neural correlates of obsessive-compulsive related dysfunctional beliefs.
    Alonso P; Orbegozo A; Pujol J; López-Solà C; Fullana MÀ; Segalàs C; Real E; Subirà M; Martínez-Zalacaín I; Menchón JM; Harrison BJ; Cardoner N; Soriano-Mas C
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Dec; 47():25-32. PubMed ID: 23911440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human PET studies of metabotropic glutamate receptor subtype 5 with 11C-ABP688.
    Ametamey SM; Treyer V; Streffer J; Wyss MT; Schmidt M; Blagoev M; Hintermann S; Auberson Y; Gasparini F; Fischer UC; Buck A
    J Nucl Med; 2007 Feb; 48(2):247-52. PubMed ID: 17268022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of Long-Term Nicotine Abstinence With Normal Metabotropic Glutamate Receptor-5 Binding.
    Akkus F; Treyer V; Johayem A; Ametamey SM; Mancilla BG; Sovago J; Buck A; Hasler G
    Biol Psychiatry; 2016 Mar; 79(6):474-80. PubMed ID: 25861697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabotropic Glutamate Receptor Type 5 (mGluR5) Cortical Abnormalities in Focal Cortical Dysplasia Identified In Vivo With [11C]ABP688 Positron-Emission Tomography (PET) Imaging.
    DuBois JM; Rousset OG; Guiot MC; Hall JA; Reader AJ; Soucy JP; Rosa-Neto P; Kobayashi E
    Cereb Cortex; 2016 Oct; 26(11):4170-4179. PubMed ID: 27578494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Degree connectivity in body dysmorphic disorder and relationships with obsessive and compulsive symptoms.
    Beucke JC; Sepulcre J; Buhlmann U; Kathmann N; Moody T; Feusner JD
    Eur Neuropsychopharmacol; 2016 Oct; 26(10):1657-66. PubMed ID: 27514293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Test-retest variability of [
    Smart K; Cox SML; Nagano-Saito A; Rosa-Neto P; Leyton M; Benkelfat C
    Synapse; 2018 Sep; 72(9):e22041. PubMed ID: 29935121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electrical stimulation of the inferior thalamic peduncle in the treatment of major depression and obsessive compulsive disorders.
    Jiménez F; Nicolini H; Lozano AM; Piedimonte F; Salín R; Velasco F
    World Neurosurg; 2013; 80(3-4):S30.e17-25. PubMed ID: 22824558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Higher serotonin transporter availability in early-onset obsessive-compulsive disorder patients undergoing escitalopram treatment: A [
    Lee J; Kim BH; Kim E; Howes OD; Cho KIK; Yoon YB; Kwon JS
    Hum Psychopharmacol; 2018 Jan; 33(1):. PubMed ID: 29210107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. N-acetylcysteine- and MK-801-induced changes in glutamate levels do not affect in vivo binding of metabotropic glutamate 5 receptor radioligand 11C-ABP688 in rat brain.
    Wyckhuys T; Verhaeghe J; Wyffels L; Langlois X; Schmidt M; Stroobants S; Staelens S
    J Nucl Med; 2013 Nov; 54(11):1954-61. PubMed ID: 24050937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serotonin 2A receptors in obsessive-compulsive disorder: a positron emission tomography study with [11C]MDL 100907.
    Simpson HB; Slifstein M; Bender J; Xu X; Hackett E; Maher MJ; Abi-Dargham A
    Biol Psychiatry; 2011 Nov; 70(9):897-904. PubMed ID: 21855857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decreased thalamic glutamate level in unmedicated adult obsessive-compulsive disorder patients detected by proton magnetic resonance spectroscopy.
    Zhu Y; Fan Q; Han X; Zhang H; Chen J; Wang Z; Zhang Z; Tan L; Xiao Z; Tong S; Maletic-Savatic M; Li Y
    J Affect Disord; 2015 Jun; 178():193-200. PubMed ID: 25819113
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo characterization of metabotropic glutamate receptor type 5 abnormalities in behavioral variant FTD.
    Leuzy A; Zimmer ER; Dubois J; Pruessner J; Cooperman C; Soucy JP; Kostikov A; Schirmaccher E; Désautels R; Gauthier S; Rosa-Neto P
    Brain Struct Funct; 2016 Apr; 221(3):1387-402. PubMed ID: 25596865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dopamine D1 receptor binding in the striatum of patients with obsessive-compulsive disorder.
    Olver JS; O'Keefe G; Jones GR; Burrows GD; Tochon-Danguy HJ; Ackermann U; Scott A; Norman TR
    J Affect Disord; 2009 Apr; 114(1-3):321-6. PubMed ID: 18706700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Limbic system mGluR5 availability in cocaine dependent subjects: a high-resolution PET [(11)C]ABP688 study.
    Milella MS; Marengo L; Larcher K; Fotros A; Dagher A; Rosa-Neto P; Benkelfat C; Leyton M
    Neuroimage; 2014 Sep; 98():195-202. PubMed ID: 24795154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The serotonin transporter availability in untreated early-onset and late-onset patients with obsessive-compulsive disorder.
    Hesse S; Stengler K; Regenthal R; Patt M; Becker GA; Franke A; Knüpfer H; Meyer PM; Luthardt J; Jahn I; Lobsien D; Heinke W; Brust P; Hegerl U; Sabri O
    Int J Neuropsychopharmacol; 2011 Jun; 14(5):606-17. PubMed ID: 21232166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Salivary alpha-amylase and cortisol responsiveness following electrical stimulation stress in obsessive-compulsive disorder patients.
    Kawano A; Tanaka Y; Ishitobi Y; Maruyama Y; Ando T; Inoue A; Okamoto S; Imanaga J; Kanehisa M; Higuma H; Ninomiya T; Tsuru J; Akiyoshi J
    Psychiatry Res; 2013 Aug; 209(1):85-90. PubMed ID: 23266021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neural correlates of moral sensitivity in obsessive-compulsive disorder.
    Harrison BJ; Pujol J; Soriano-Mas C; Hernández-Ribas R; López-Solà M; Ortiz H; Alonso P; Deus J; Menchon JM; Real E; Segalàs C; Contreras-Rodríguez O; Blanco-Hinojo L; Cardoner N
    Arch Gen Psychiatry; 2012 Jul; 69(7):741-9. PubMed ID: 22752238
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced metabotropic glutamate receptor 5 density in major depression determined by [(11)C]ABP688 PET and postmortem study.
    Deschwanden A; Karolewicz B; Feyissa AM; Treyer V; Ametamey SM; Johayem A; Burger C; Auberson YP; Sovago J; Stockmeier CA; Buck A; Hasler G
    Am J Psychiatry; 2011 Jul; 168(7):727-34. PubMed ID: 21498461
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cerebral glucose metabolism in obsessive-compulsive hoarding.
    Saxena S; Brody AL; Maidment KM; Smith EC; Zohrabi N; Katz E; Baker SK; Baxter LR
    Am J Psychiatry; 2004 Jun; 161(6):1038-48. PubMed ID: 15169692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patients with obsessive-compulsive disorder have increased 5-HT2A receptor binding in the caudate nuclei.
    Adams KH; Hansen ES; Pinborg LH; Hasselbalch SG; Svarer C; Holm S; Bolwig TG; Knudsen GM
    Int J Neuropsychopharmacol; 2005 Sep; 8(3):391-401. PubMed ID: 15801987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.